Insider · CIK 0001794564
Edward L. Murphy
Files at CODX (Co-Diagnostics, Inc.). First filing -, latest -.
In brief
Edward L. Murphy files SEC Form 4 as director at CODX (Co-Diagnostics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Edward L. Murphy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 23, 2026 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +1,695 | $0.00 | $0 | 11,084 | May 27, 2026 |
| May 23, 2026 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -1,695 | $0.00 | $0 | 4,000 | May 27, 2026 |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +57,499 | $0.00 | $0 | 281,666 | Nov 24, 2025 |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -57,499 | $0.00 | $0 | 170,834 | Nov 24, 2025 |
Questions about Edward L. Murphy
Answered from the filings on this page, as of the latest one.
Is Edward L. Murphy buying or selling?
Edward L. Murphy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Edward L. Murphy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Edward L. Murphy has 0.
Where does Edward L. Murphy file Form 4?
Edward L. Murphy has filed Form 4 at CODX (Co-Diagnostics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.